©Celoxica 2008. T: +44 (0)1235 863656
News and announcements
17 Sept 07
CELOXICA HOLDINGS PLC
(“CELOXICA” OR “THE COMPANY”)
CELOXICA ACCELERATION CARDS QUALIFIED IN HP SERVERS
Qualification of Celoxica Hardware Expands Accelerated Computing Market Opportunities
Celoxica Holdings plc (AIM: CXA) - a leading provider of electronic system level design technology for the Accelerated Computing and Embedded Systems markets, is pleased to announce that the Company’s RCHTX acceleration board has passed HP qualification tests, expanding the opportunities for Celoxica’s hardware in the Accelerated Computing market. The board is now available for integration in HP ProLiant DL145 G3 server-based HP Unified Cluster Portfolio solutions for high-performance computing.
Celoxica’s RCHTX board, available immediately in volume production, is a plug-in acceleration card for high-performance servers. The Company is working with HP and other server partners to provide power-efficient acceleration technology that increases system performance, scalability and flexibility. Celoxica is also in collaboration with AMD’s Torrenza Initiative to optimize accelerator-to-processor communication speeds. The RCHTX card fits in a HyperTransportTM (HTX) socket on the HP ProLiant DL145 server and employs the HTX interface standard to provide rapid communication between a Xilinx Virtex-4TM FPGA co-processor and AMD’s OpteronTM processors.
Celoxica accelerator technology is used in the Financial Services, Energy and Life Sciences industries to speed performance of mission critical applications. In deployment of customer applications, the Company has achieved acceleration rates of more than 30x over existing server implementations. In addition to the RCHTX acceleration hardware, the Celoxica solution includes compilation tools that enable software programming of customer applications on the FPGA co-processor. At the High Performance on Wall Street Conference in New York on 17 September, the Company is demonstrating an accelerated financial application running on the HP ProLiant DL145 server with an RCHTX accelerator.
Lee Staines, chief executive of Celoxica commented, “We believe that Celoxica’s acceleration solutions provide a unique advantage in programmability, power efficiency and performance. The qualification of Celoxica hardware by HP is a critical milestone in the development and growth of the market for FPGA-based accelerators. Customers can purchase these accelerator cards with confidence that the technology has been proven by the leading server OEM.”
Ty Rabe, director of research and development, High Performance Computing, HP said, “The qualification of the RCHTX hardware on the HP ProLiant DL145 server provides another option for HP customers who are interested in adding acceleration co-processors to their high performance computing environments. The ability to support accelerators such as Celoxica’s RCHTX extends application performance to new levels, and provides users an alternative for dealing with power constrained environments. This collaboration shows the advantages of HP’s flexible and scalable server architecture to provide industry-leading performance.”
Doug O’Flaherty, division marketing manager for Accelerated Computing, AMD (NYSE: AMD), adds, “With the deployment of their integrated acceleration hardware, Celoxica is delivering tangible results from the Torrenza Initiative to the benefit of AMD customers. Torrenza represents the industry’s first open, customer-centric x86 innovation platform based on the Direct Connect Architecture and the AMD64 platform to enable other processor providers to innovate within a common ecosystem. AMD is dedicated to driving open innovation, choice and industry growth by offering superior solutions for customers and businesses worldwide.”
ENQUIRIES
Celoxica Holdings plc
Tel. +44 (0)1235 863 656
Lee Staines, CEO
Michelle Young, CFO
ICIS
Tel. +44 (0) 20 7651 8688
Tom Moriarty +44 (0) 7843 260 623
Caroline Evans-Jones
Arbuthnot
Tel. +44 (0) 20 7012 2000
Tom Griffiths
Alasdair Younie
AMD, the AMD Arrow logo, AMD Opteron and combinations thereof are trademarks of Advanced Micro Devices, Inc. HyperTransport is a licensed trademark of the HyperTransport Technology Consortium. Other names are for informational purposes only and may be trademarks of their respective owners.
Investor Relations section last updated 8th July 2008
